Renal Cancer - Results from #5740

EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma April 19, 2016

Thyroid-Like Follicular Carcinoma of the Kidney in a Patient with Skull and Meningeal Metastasis: A Unique Case Report and Review of the Literature April 18, 2016

Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer April 18, 2016

Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study April 18, 2016

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer April 17, 2016

Renal Splenosis: Renal Mass Biopsy Diagnosis of a Tumor Clinically Mimicking Renal Cell Carcinoma April 17, 2016

Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy April 16, 2016

The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients April 16, 2016

Small (clear cell renal cell carcinoma: correlation between CT findings and histologic grade April 15, 2016

Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma April 15, 2016

[Cryotherapy percutaneous for renal tumors: Our center's beginning experience] April 15, 2016

The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma April 15, 2016

Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome April 15, 2016

Combination therapy for metastatic renal cell carcinoma April 13, 2016

Heritable Cancer Syndromes Related to the Hypoxia Pathway April 13, 2016

Germline mutations in the VHL gene associated with three different renal lesions in a Chinese von Hippel-Lindau disease family April 12, 2016

Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients April 12, 2016

A patient with Multiple myeloma and Renal cell carcinoma April 12, 2016

Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report April 12, 2016

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma April 12, 2016

Page 288 of 456